Anticoagulant Monotherapy Does Not Increase CV Events in Coronary Artery Disease Patients with AF: Cardiovascular Center

September 6, 2019
The National Cerebral and Cardiovascular Center (NCVC) announced on September 5 the results of a study showing that stable coronary artery disease patients with atrial fibrillation (AF) who use a single anticoagulant rather than multiple antithrombotic drugs experience a decrease...read more